142 related articles for article (PubMed ID: 3354537)
1. Self-reports of mole counts and cutaneous malignant melanoma in women: methodological issues and risk of disease.
Bain C; Colditz GA; Willett WC; Stampfer MJ; Green A; Bronstein BR; Mihm MC; Rosner B; Hennekens CH; Speizer FE
Am J Epidemiol; 1988 Apr; 127(4):703-12. PubMed ID: 3354537
[TBL] [Abstract][Full Text] [Related]
2. Moles and site-specific risk of nonfamilial cutaneous malignant melanoma in women.
Weinstock MA; Colditz GA; Willett WC; Stampfer MJ; Bronstein BR; Mihm MC; Speizer FE
J Natl Cancer Inst; 1989 Jun; 81(12):948-52. PubMed ID: 2733040
[TBL] [Abstract][Full Text] [Related]
3. The transformation rate of moles (melanocytic nevi) into cutaneous melanoma: a population-based estimate.
Tsao H; Bevona C; Goggins W; Quinn T
Arch Dermatol; 2003 Mar; 139(3):282-8. PubMed ID: 12622618
[TBL] [Abstract][Full Text] [Related]
4. Height, nevus count, and risk of cutaneous malignant melanoma: Results from 2 large cohorts of US women.
Li X; Kraft P; De Vivo I; Giovannucci E; Liang L; Nan H
J Am Acad Dermatol; 2020 Oct; 83(4):1049-1056. PubMed ID: 32376423
[TBL] [Abstract][Full Text] [Related]
5. Risk of cutaneous melanoma in relation to the numbers, types and sites of naevi: a case-control study.
Bataille V; Bishop JA; Sasieni P; Swerdlow AJ; Pinney E; Griffiths K; Cuzick J
Br J Cancer; 1996 Jun; 73(12):1605-11. PubMed ID: 8664138
[TBL] [Abstract][Full Text] [Related]
6. Association of Phenotypic Characteristics and UV Radiation Exposure With Risk of Melanoma on Different Body Sites.
Ghiasvand R; Robsahm TE; Green AC; Rueegg CS; Weiderpass E; Lund E; Veierød MB
JAMA Dermatol; 2019 Jan; 155(1):39-49. PubMed ID: 30477003
[TBL] [Abstract][Full Text] [Related]
7. Self screening for risk of melanoma: validity of self mole counting by patients in a single general practice.
Little P; Keefe M; White J
BMJ; 1995 Apr; 310(6984):912-6. PubMed ID: 7719184
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous nevi and risk of melanoma death in women and men: A prospective study.
Li WQ; Cho E; Weinstock MA; Li S; Stampfer MJ; Qureshi AA
J Am Acad Dermatol; 2019 May; 80(5):1284-1291. PubMed ID: 30639880
[TBL] [Abstract][Full Text] [Related]
9. Pigmentary characteristics and moles in relation to melanoma risk.
Titus-Ernstoff L; Perry AE; Spencer SK; Gibson JJ; Cole BF; Ernstoff MS
Int J Cancer; 2005 Aug; 116(1):144-9. PubMed ID: 15761869
[TBL] [Abstract][Full Text] [Related]
10. Number of nevi at a specific anatomical site and its relation to cutaneous malignant melanoma.
Randi G; Naldi L; Gallus S; Di Landro A; La Vecchia C;
J Invest Dermatol; 2006 Sep; 126(9):2106-10. PubMed ID: 16645584
[TBL] [Abstract][Full Text] [Related]
11. Naevi and pigmentary characteristics as risk factors for melanoma in a high-risk population: a case-control study in New South Wales, Australia.
Grulich AE; Bataille V; Swerdlow AJ; Newton-Bishop JA; Cuzick J; Hersey P; McCarthy WH
Int J Cancer; 1996 Aug; 67(4):485-91. PubMed ID: 8759605
[TBL] [Abstract][Full Text] [Related]
12. Nevus density and melanoma risk in women: a pooled analysis to test the divergent pathway hypothesis.
Olsen CM; Zens MS; Stukel TA; Sacerdote C; Chang YM; Armstrong BK; Bataille V; Berwick M; Elwood JM; Holly EA; Kirkpatrick C; Mack T; Bishop JN; Østerlind A; Swerdlow AJ; Zanetti R; Green AC; Karagas MR; Whiteman DC
Int J Cancer; 2009 Feb; 124(4):937-44. PubMed ID: 19035450
[TBL] [Abstract][Full Text] [Related]
13. Solar elastosis and cutaneous melanoma: a site-specific analysis.
Kvaskoff M; Pandeya N; Green AC; Perry S; Baxter C; Davis MB; Mortimore R; Westacott L; Wood D; Triscott J; Williamson R; Whiteman DC
Int J Cancer; 2015 Jun; 136(12):2900-11. PubMed ID: 25403328
[TBL] [Abstract][Full Text] [Related]
14. Prediction of high naevus count in a healthy U.K. population to estimate melanoma risk.
Ribero S; Zugna D; Osella-Abate S; Glass D; Nathan P; Spector T; Bataille V
Br J Dermatol; 2016 Feb; 174(2):312-8. PubMed ID: 26479165
[TBL] [Abstract][Full Text] [Related]
15. Total Nevi, Atypical Nevi, and Melanoma Thickness: An Analysis of 566 Patients at 2 US Centers.
Geller AC; Mayer JE; Sober AJ; Miller DR; Argenziano G; Johnson TM; Swetter SM
JAMA Dermatol; 2016 Apr; 152(4):413-8. PubMed ID: 26934430
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for melanoma by body site.
Cho E; Rosner BA; Colditz GA
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1241-4. PubMed ID: 15894679
[TBL] [Abstract][Full Text] [Related]
17. Individual risk of cutaneous melanoma in New Zealand: developing a clinical prediction aid.
Sneyd MJ; Cameron C; Cox B
BMC Cancer; 2014 May; 14():359. PubMed ID: 24884419
[TBL] [Abstract][Full Text] [Related]
18. Sun and solarium exposure and melanoma risk: effects of age, pigmentary characteristics, and nevi.
Veierød MB; Adami HO; Lund E; Armstrong BK; Weiderpass E
Cancer Epidemiol Biomarkers Prev; 2010 Jan; 19(1):111-20. PubMed ID: 20056629
[TBL] [Abstract][Full Text] [Related]
19. Overall and site-specific risk of malignant melanoma associated with nevus counts at different body sites: a multicenter case-control study of the German Central Malignant-Melanoma Registry.
Rieger E; Soyer HP; Garbe C; Büttner P; Kofler R; Weiss J; Stocker U; Krüger S; Roser M; Weckbecker J
Int J Cancer; 1995 Aug; 62(4):393-7. PubMed ID: 7635564
[TBL] [Abstract][Full Text] [Related]
20. Association of Patient Risk Factors and Frequency of Nevus-Associated Cutaneous Melanomas.
Haenssle HA; Mograby N; Ngassa A; Buhl T; Emmert S; Schön MP; Rosenberger A; Bertsch HP
JAMA Dermatol; 2016 Mar; 152(3):291-8. PubMed ID: 26536613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
